Status:
COMPLETED
Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer
Lead Sponsor:
Chinese Academy of Medical Sciences
Conditions:
Cervical Cancer
Eligibility:
FEMALE
25-70 years
Phase:
NA
Brief Summary
For stage Ib2-IIa2 cervical cancer patients, neoadjuvant therapy followed by radical hysterectomy and pelvic lymphadenectomy is one of the managements. Post-operative concurrent chemo-radiotherapy is ...
Detailed Description
In the present study, the patients with stage Ib2-IIa2 cervical cancer will receive either neoadjuvant chemo/brachytherapy or neoadjuvant chemotherapy before radical hysterectomy and pelvic+/- para-ao...
Eligibility Criteria
Inclusion
- Histology confirmed cervical cancer
- Clinical stage Ib2 or IIa2 (FIGO 2009)
Exclusion
- Patients who not suitable for surgery
- Personal history of pelvic radiotherapy
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03243825
Start Date
November 1 2012
End Date
July 1 2015
Last Update
August 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital, Chinese Acadamy of Medical Sceinces
Beijing, China, 100021